Company Profile
Nucleome Therapeutics Limited
12109297•Private Limited With Share Capital
Get Full Access
17/07/2019
6 years
9
44
72110
moderate risk
Company Overview
Registration, classification & business activity
Nucleome Therapeutics Limited (12109297) is a private limited with share capital incorporated on 17/07/2019 (6 years old) and registered in oxford, OX20HA. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Nucleome therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. the dark genome holds more than 90% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. the company ha...
Financial Overview
£24.34M
£1.31M
£23.03M
£156.1K
£12.29M
Key Metrics
44
Employees
9
Directors
30
Shareholders
1
Patents
Board of Directors
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating